{"id":55004,"date":"2023-03-20T19:03:11","date_gmt":"2023-03-20T18:03:11","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/diabetes-drug-drives-patient-demand-for-fotona-4d-non-surgical-facelift-procedure\/"},"modified":"2023-03-20T19:03:11","modified_gmt":"2023-03-20T18:03:11","slug":"diabetes-drug-drives-patient-demand-for-fotona-4d-non-surgical-facelift-procedure","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/diabetes-drug-drives-patient-demand-for-fotona-4d-non-surgical-facelift-procedure\/","title":{"rendered":"Diabetes Drug Drives Patient Demand for Fotona 4D Non Surgical Facelift Procedure"},"content":{"rendered":"
\n

DALLAS–(BUSINESS WIRE)–Fotona US, the leader in the design and manufacture of high technology laser systems for aesthetics and dentistry since 1964, has noted a significant demand for Fotona 4D\u00ae Non Surgical Facelift procedures to rebuild collagen and correct sagging facial skin due to the popular off label use of a diabetes drug.\n<\/p>\n

<\/a><\/p>\n

\n\u201cDiabetes drugs like semaglutide injections are in high demand for rapid weight loss. Now more users are noticing an unwanted side effect: the ‘Ozempic face,’ which refers to the facial aging and sagging that some users have experienced,\u201d states Board Certified Dermatologist Martha Viera from Coral Gables, Florida. \u201cEven if you add back volume through fillers, the skin is not going to return right back to normal. We need to use the Fotona 4D\u00ae procedure to restore skin\u2019s elasticity and achieve lifting and tightening to reduce the sagging, as well as restore a patient\u2019s facial volume.\u201d\n<\/p>\n

\nThe Fotona 4D\u00ae procedure is a series of synergistic, non-invasive laser treatments of both the exterior facial and interior oral cavity, enabling two complimentary laser wavelengths to treat 4 distinct \u201cdimensions\u201d of the skin to rejuvenate and tighten from the inside out. Dr. Viera adds, \u201cIt offers tightening and volumization without the need for fillers or toxins which only last between 6 and 10 months. Instead, Fotona 4D\u00ae has the ability to promote collagen production with long lasting results, therefore giving the opportunity for patients to restore and build their own collagen in a more natural manner.\u201d\n<\/p>\n

\nDepending on the severity of volume loss, patients can expect an initial series of 3 to 5 laser treatments over the course of a few months. Once volume is restored, it is recommended to have an additional treatment every 12-16 months to combat volume loss due to the normal aging process. Treatments are conducted in a physician\u2019s office with minimal downtime.\n<\/p>\n

\nAccording to Dimas Garcia, President and CEO of Fotona US: \u201cOur technological innovations have created new, minimally invasive laser treatment options that patients are more motivated to take advantage of due to limited or no downtime. We have successfully maintained this approach across many other specialties, and physicians around the world use Fotona lasers to address indications from \u2018head to toe,\u2019 whether that be chronic snoring, volume and laxity throughout body, persistent melasma, and even onychomycosis, otherwise known as toe nail fungus.\u201d\n<\/p>\n

\nFotona US is a world-leading medical laser company recognized for its innovative, award-winning laser systems<\/a> for applications in aesthetics & dermatology, dentistry, surgery and gynecology. The company has one of the most highly educated workforces in the industry, with an exceptionally high number of PhDs specializing in laser and medical technology innovation. In addition to its direct presence in the US and EU, Fotona\u2019s global distribution network spans across more than 70 countries, ensuring comprehensive support and service for Fotona laser users, including clinical training. www.fotona4D.com<\/a>\n<\/p>\n

Contacts<\/b> <\/p>\n

\nAimee Desrosiers, Apiarium
\n
aimee@apiarium.agency<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

DALLAS–(BUSINESS WIRE)–Fotona US, the leader in the design and manufacture of high technology laser systems for aesthetics and dentistry since 1964, has noted a significant demand for Fotona 4D\u00ae Non Surgical Facelift procedures to rebuild collagen and correct sagging facial skin due to the popular off label use of a diabetes drug. \u201cDiabetes drugs like … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-55004","6":"format-standard","7":"category-industry"},"yoast_head":"\nDiabetes Drug Drives Patient Demand for Fotona 4D Non Surgical Facelift Procedure - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/diabetes-drug-drives-patient-demand-for-fotona-4d-non-surgical-facelift-procedure\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Diabetes Drug Drives Patient Demand for Fotona 4D Non Surgical Facelift Procedure - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DALLAS–(BUSINESS WIRE)–Fotona US, the leader in the design and manufacture of high technology laser systems for aesthetics and dentistry since 1964, has noted a significant demand for Fotona 4D\u00ae Non Surgical Facelift procedures to rebuild collagen and correct sagging facial skin due to the popular off label use of a diabetes drug. \u201cDiabetes drugs like ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/diabetes-drug-drives-patient-demand-for-fotona-4d-non-surgical-facelift-procedure\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-03-20T18:03:11+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230320005596\/en\/1742644\/21\/Fotona_4D_logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/diabetes-drug-drives-patient-demand-for-fotona-4d-non-surgical-facelift-procedure\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/diabetes-drug-drives-patient-demand-for-fotona-4d-non-surgical-facelift-procedure\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Diabetes Drug Drives Patient Demand for Fotona 4D Non Surgical Facelift Procedure\",\"datePublished\":\"2023-03-20T18:03:11+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/diabetes-drug-drives-patient-demand-for-fotona-4d-non-surgical-facelift-procedure\\\/\"},\"wordCount\":495,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/diabetes-drug-drives-patient-demand-for-fotona-4d-non-surgical-facelift-procedure\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230320005596\\\/en\\\/1742644\\\/21\\\/Fotona_4D_logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/diabetes-drug-drives-patient-demand-for-fotona-4d-non-surgical-facelift-procedure\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/diabetes-drug-drives-patient-demand-for-fotona-4d-non-surgical-facelift-procedure\\\/\",\"name\":\"Diabetes Drug Drives Patient Demand for Fotona 4D Non Surgical Facelift Procedure - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/diabetes-drug-drives-patient-demand-for-fotona-4d-non-surgical-facelift-procedure\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/diabetes-drug-drives-patient-demand-for-fotona-4d-non-surgical-facelift-procedure\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230320005596\\\/en\\\/1742644\\\/21\\\/Fotona_4D_logo.jpg\",\"datePublished\":\"2023-03-20T18:03:11+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/diabetes-drug-drives-patient-demand-for-fotona-4d-non-surgical-facelift-procedure\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/diabetes-drug-drives-patient-demand-for-fotona-4d-non-surgical-facelift-procedure\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/diabetes-drug-drives-patient-demand-for-fotona-4d-non-surgical-facelift-procedure\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230320005596\\\/en\\\/1742644\\\/21\\\/Fotona_4D_logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230320005596\\\/en\\\/1742644\\\/21\\\/Fotona_4D_logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/diabetes-drug-drives-patient-demand-for-fotona-4d-non-surgical-facelift-procedure\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Diabetes Drug Drives Patient Demand for Fotona 4D Non Surgical Facelift Procedure\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Diabetes Drug Drives Patient Demand for Fotona 4D Non Surgical Facelift Procedure - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/diabetes-drug-drives-patient-demand-for-fotona-4d-non-surgical-facelift-procedure\/","og_locale":"en_US","og_type":"article","og_title":"Diabetes Drug Drives Patient Demand for Fotona 4D Non Surgical Facelift Procedure - Pharma Trend","og_description":"DALLAS–(BUSINESS WIRE)–Fotona US, the leader in the design and manufacture of high technology laser systems for aesthetics and dentistry since 1964, has noted a significant demand for Fotona 4D\u00ae Non Surgical Facelift procedures to rebuild collagen and correct sagging facial skin due to the popular off label use of a diabetes drug. \u201cDiabetes drugs like ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/diabetes-drug-drives-patient-demand-for-fotona-4d-non-surgical-facelift-procedure\/","og_site_name":"Pharma Trend","article_published_time":"2023-03-20T18:03:11+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230320005596\/en\/1742644\/21\/Fotona_4D_logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/diabetes-drug-drives-patient-demand-for-fotona-4d-non-surgical-facelift-procedure\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/diabetes-drug-drives-patient-demand-for-fotona-4d-non-surgical-facelift-procedure\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Diabetes Drug Drives Patient Demand for Fotona 4D Non Surgical Facelift Procedure","datePublished":"2023-03-20T18:03:11+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/diabetes-drug-drives-patient-demand-for-fotona-4d-non-surgical-facelift-procedure\/"},"wordCount":495,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/diabetes-drug-drives-patient-demand-for-fotona-4d-non-surgical-facelift-procedure\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230320005596\/en\/1742644\/21\/Fotona_4D_logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/diabetes-drug-drives-patient-demand-for-fotona-4d-non-surgical-facelift-procedure\/","url":"https:\/\/pharma-trend.com\/en\/diabetes-drug-drives-patient-demand-for-fotona-4d-non-surgical-facelift-procedure\/","name":"Diabetes Drug Drives Patient Demand for Fotona 4D Non Surgical Facelift Procedure - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/diabetes-drug-drives-patient-demand-for-fotona-4d-non-surgical-facelift-procedure\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/diabetes-drug-drives-patient-demand-for-fotona-4d-non-surgical-facelift-procedure\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230320005596\/en\/1742644\/21\/Fotona_4D_logo.jpg","datePublished":"2023-03-20T18:03:11+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/diabetes-drug-drives-patient-demand-for-fotona-4d-non-surgical-facelift-procedure\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/diabetes-drug-drives-patient-demand-for-fotona-4d-non-surgical-facelift-procedure\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/diabetes-drug-drives-patient-demand-for-fotona-4d-non-surgical-facelift-procedure\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230320005596\/en\/1742644\/21\/Fotona_4D_logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230320005596\/en\/1742644\/21\/Fotona_4D_logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/diabetes-drug-drives-patient-demand-for-fotona-4d-non-surgical-facelift-procedure\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Diabetes Drug Drives Patient Demand for Fotona 4D Non Surgical Facelift Procedure"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/55004","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=55004"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/55004\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=55004"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=55004"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=55004"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}